IBDEI0W1 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15022,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,15022,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,15022,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,15023,0)
 ;;=I25.9^^56^636^10
 ;;^UTILITY(U,$J,358.3,15023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15023,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,15023,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,15023,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,15024,0)
 ;;=I35.0^^56^636^17
 ;;^UTILITY(U,$J,358.3,15024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15024,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,15024,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,15024,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,15025,0)
 ;;=I35.1^^56^636^16
 ;;^UTILITY(U,$J,358.3,15025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15025,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,15025,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,15025,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,15026,0)
 ;;=I35.2^^56^636^18
 ;;^UTILITY(U,$J,358.3,15026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15026,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,15026,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,15026,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,15027,0)
 ;;=I35.8^^56^636^14
 ;;^UTILITY(U,$J,358.3,15027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15027,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders,Other
 ;;^UTILITY(U,$J,358.3,15027,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,15027,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,15028,0)
 ;;=I35.9^^56^636^15
 ;;^UTILITY(U,$J,358.3,15028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15028,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders,Unspec
 ;;^UTILITY(U,$J,358.3,15028,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,15028,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,15029,0)
 ;;=I48.91^^56^636^5
 ;;^UTILITY(U,$J,358.3,15029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15029,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,15029,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,15029,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,15030,0)
 ;;=I49.9^^56^636^8
 ;;^UTILITY(U,$J,358.3,15030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15030,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,15030,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,15030,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,15031,0)
 ;;=I50.9^^56^636^12
 ;;^UTILITY(U,$J,358.3,15031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15031,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,15031,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,15031,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,15032,0)
 ;;=I73.9^^56^636^19
 ;;^UTILITY(U,$J,358.3,15032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15032,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,15032,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,15032,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,15033,0)
 ;;=I87.2^^56^636^26
 ;;^UTILITY(U,$J,358.3,15033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15033,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,15033,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,15033,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,15034,0)
 ;;=R03.0^^56^636^11
 ;;^UTILITY(U,$J,358.3,15034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15034,1,3,0)
 ;;=3^Elevated B/P Reading w/o HTN Dx
 ;;^UTILITY(U,$J,358.3,15034,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,15034,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,15035,0)
 ;;=I25.110^^56^636^3
 ;;^UTILITY(U,$J,358.3,15035,1,0)
 ;;=^358.31IA^4^2
